综述风湿性关节炎相关的间歇性肺部疾病及其治疗方法
Janelle Vu Pugashetti1, Joyce S Lee2
1Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.
Seminars in respiratory and critical care medicine
|March 14, 2024
概括
风湿性关节炎相关的间歇性肺病 (RA-ILD) 治疗正在发展. 目前的策略包括免疫抑制和抗纤维菌药物,正在进行针对个性化治疗选择的研究.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 风湿性关节炎相关的间歇性肺病 (RA-ILD) 是一种严重的并发症.
- 对于RA-ILD的最佳治疗和预后指标仍未确定.
- 目前的治疗决定在很大程度上依赖于临床判断.
研究的目的:
- 审查目前对RA-ILD的理解和治疗方法.
- 突出新兴的治疗选择和未来的研究方向.
主要方法:
- 对回顾性数据和最近随机对照试验的审查.
- 在RA-ILD中分析免疫抑制剂和抗纤维素药物的治疗疗效.
主要成果:
- 免疫抑制剂,如基酸莫菲蒂尔,阿扎西奥普林,利图西马布和阿巴塔切普特,显示出有前途的结果.
- 抗纤维素药物 (nintedanib,pirfenidone) 可以减缓强迫生命能力的下降.
- 免疫抑制可能有利于患者,无论成像模式 (UIP).
结论:
- 建议在有症状,进展或高风险的RA-ILD患者开始治疗.
- 可能考虑使用免疫抑制和抗纤维素药物的联合治疗.
- 未来的研究应该专注于疾病进展和治疗反应的预测工具.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:17Other Pulmonary Disorders
838
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
838
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
01:28Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
01:28Pleural Effusion II: Symptoms and Management
166
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
166